Archives of Cardiovascular Diseases最新文献

{"title":"A clinician viewpoint on the 2024 European guidelines on the management of patients with atrial fibrillation.","authors":"Laurent Fauchier, Jean Claude Deharo, Frederic Sacher, Ariel Cohen","doi":"10.1016/j.acvd.2024.12.003","DOIUrl":"https://doi.org/10.1016/j.acvd.2024.12.003","url":null,"abstract":"","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142873569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous circulatory assistance in an interventional cardiology centre without on-site cardiac surgery.","authors":"Ibrahim Hatoum, Paul Luporsi, Philippe Riccini, Frédéric Collart, Ziad Boueri","doi":"10.1016/j.acvd.2024.10.331","DOIUrl":"https://doi.org/10.1016/j.acvd.2024.10.331","url":null,"abstract":"<p><strong>Background: </strong>Percutaneous extracorporeal membrane oxygenation (ECMO) has been developed thanks to the progress in the field of cannulation, but still justifies the presence of an on-site cardiac resuscitation department. Corsica is a French island without an on-site cardiac surgery department.</p><p><strong>Aim: </strong>To evaluate the percutaneous ECMO programme in Corsica.</p><p><strong>Methods: </strong>All patients who received ECMO at the Bastia Hospital Centre between 01 January 2016 and 30 April 2022 were included.</p><p><strong>Results: </strong>ECMO was implanted in 39 patients. The mean age was 52.7years, with male predominance (84.6%). The majority of veno-arterial ECMOs were placed in the coronary angiography laboratory, whereas venovenous ECMOs were preferentially placed in the medical intensive care unit. Twenty patients (51.3%) were medically transferred to other referral centres after canulation. Percutaneous vascular cannulation was performed with ultrasound guidance in all cases (100%), and was successfully performed without immediate complications in all patients except two (who presented an immediate complication during cannulation), which is similar to large trials, despite the absence of on-site cardiac surgery. The use of ultrasound guidance (and sometimes fluoroscopy guidance) during cannulation and the experience of the medical team facilitated control over correct positioning of the cannulas and decreased implantation failure, without the need for a surgical approach.</p><p><strong>Conclusions: </strong>Percutaneous ECMO by trained interventional cardiologists without a surgical approach appears to be safe. Widespread use of percutaneous cannulation without cardiac surgery would increase survival for some patients who are far from these centres.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142866497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of venous thromboembolism in France.","authors":"Amélie Gabet, Jacques Blacher, Philippe Tuppin, Grégory Lailler, Clémence Grave, Olivier Sanchez, Isabelle Mahe, Joseph Emmerich, Valérie Olié","doi":"10.1016/j.acvd.2024.10.325","DOIUrl":"10.1016/j.acvd.2024.10.325","url":null,"abstract":"<p><strong>Background: </strong>Few epidemiological data are available for venous thromboembolism (VTE) at French national and subnational levels.</p><p><strong>Aims: </strong>To quantify VTE events in France in 2022 and describe the features of hospital management and outcomes.</p><p><strong>Methods: </strong>Adults hospitalized for a VTE as the primary reason for hospitalization or treatment in a medical unit in 2022 were identified from medical administrative data. Data were stratified as pulmonary embolism (PE) and deep vein thrombosis (DVT), and by French department and various sociodemographic indicators. VTE prevalence at 1 January 2023 was defined as the number of people alive at that date with a history of hospitalization for VTE or a chronic long-term disease status due to VTE (2012-2022).</p><p><strong>Results: </strong>VTE cases reached 896,846 adults on 1 January 2023. VTE was the primary diagnosis for a hospital stay or medical unit in 62,055 patients hospitalized in 2022. The age-standardized rate of hospitalized patients was 23.0% higher for men versus women. There were considerable variations between departments of residence, while Martinique had the highest age-standardized rate. The prevalence of triggering factors was high, with almost 30% having cancer and 20% a recent long hospitalization. One-year mortality was approximately 20% for both PE and DVT, despite rehospitalization rates <5%.</p><p><strong>Conclusion: </strong>The high prevalence of cancer among patients hospitalized due to VTE partly explains the high 1-year mortality. As VTE is partially avoidable, the prevention of VTE needs to be improved in France and whether thromboprophylaxis guidance is being followed should regularly be assessed.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"715-724"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of heart failure in France.","authors":"Amélie Gabet, Jacques Blacher, Françoise Pousset, Clémence Grave, Grégory Lailler, Philippe Tuppin, Malika Saadi, Ariel Cohen, Damien Logeart, Richard Isnard, Valérie Olié","doi":"10.1016/j.acvd.2024.10.004","DOIUrl":"10.1016/j.acvd.2024.10.004","url":null,"abstract":"<p><strong>Background: </strong>Heart failure (HF) prevalence may increase because of population ageing and has become a major public health issue in European countries.</p><p><strong>Aim: </strong>To update the epidemiology of HF in France in 2022.</p><p><strong>Methods: </strong>Adults hospitalized for HF in 2022 were identified in the National Health Data System (SNDS) and followed up for 1year. The first stay of the year was taken as the index hospitalization. The prevalence of HF was estimated by combining hospitalization data and patients with 100% coverage for a long-term disease associated with HF. Patients and their hospital stays were described on the basis of the sociodemographic and medical information in the SNDS.</p><p><strong>Results: </strong>In 2022, 181,178 adults were hospitalized for HF in France, which equates to a crude rate of 339.3 per 100,000 inhabitants, and 1,376,692 prevalent cases of HF were recorded, which is an estimated prevalence of 2.6% in the adult population. For people living in the most socioeconomically deprived municipalities, the rate of hospitalization was 1.6 times higher than for those living in the least deprived municipalities. The departments of Haut-de-France and Réunion Island, and some departments in Normandy and the Grand-Est had much higher rates than others. The fatality rate was 10.2% in hospital, and 34.0% at 1year. Only 20.1% of patients were admitted to a rehabilitation unit within 6months, and 47.9% of patients alive at 1year were being treated with a combination of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and beta-blockers.</p><p><strong>Conclusions: </strong>The large number of people hospitalized for HF, and the fact that rates vary across the different French departments, means that more ambitious general cardiovascular prevention measures are needed, and that healthcare provision needs significant adaptation. Short-term patient outcomes could be improved by following recommendations more closely and taking into account patients' social circumstances.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"705-714"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of major heart rhythm and conduction disorders.","authors":"Amélie Gabet, Grégory Lailler, Laurent Fauchier, Jean-Claude Deharo, Philippe Tuppin, Christophe Leclercq, Walid Amara, Clémence Grave, Jacques Blacher, Valérie Olié","doi":"10.1016/j.acvd.2024.10.003","DOIUrl":"10.1016/j.acvd.2024.10.003","url":null,"abstract":"<p><strong>Background: </strong>Heart rhythm and conduction disorders cover a variety of pathologies, ranging from the benign to the immediately life threatening.</p><p><strong>Aims: </strong>To describe the epidemiology of patients hospitalized for arrhythmias in France, and to estimate the prevalence and mortality associated with these disorders, divided into three separate groups: atrial fibrillation and flutter; conduction disorders; and ventricular tachycardia/cardiac arrest.</p><p><strong>Methods: </strong>We looked in the National Health Data System and selected patients who had been hospitalized at least once in 2022 for these diseases and patients who died as a result of these diseases in 2021. The prevalence of these disorders among people alive on 1st January 2023 was estimated by combining previous hospitalizations and people in receipt of 100% coverage for a registered long-term disease.</p><p><strong>Results: </strong>At 1st January 2023, the prevalence of patients who had been hospitalized with major rhythm and conduction disorders was 2,740,141: 2,027,900 with atrial fibrillation/flutter; 999,692 with conduction disorders; and 214,989 with ventricular tachycardia/cardiac arrest. In 2022, respectively 90,502, 48,268 and 16,930 were hospitalized for these conditions, which equate to rates of 169.5, 68.3, and 31.7 per 100,000 inhabitants, respectively. Several departments in the Hauts-de-France and Grand-Est regions had rates>20% above the national rate. The rate of ventricular tachycardia/cardiac arrest was 40% higher among residents of the most deprived municipalities than among residents of the least deprived municipalities. Mortality at the end of hospitalization reached 44% for patients hospitalized for ventricular tachycardia/cardiac arrest.</p><p><strong>Conclusions: </strong>Arrhythmias and conduction disorders affect a significant proportion of the population, leading to a large number of hospitalizations and procedures, particularly ablation techniques and pacemaker/defibrillator implantation. Given the extent of regional disparities and the impact of the socioeconomic status of the municipality of residence, targeted prevention and screening strategies should be implemented.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"693-704"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of valvular heart disease in France.","authors":"Clémence Grave, Amélie Gabet, Christophe Tribouilloy, Ariel Cohen, Grégory Lailler, Alain Weill, Philippe Tuppin, Bernard Iung, Jacques Blacher, Valérie Olié","doi":"10.1016/j.acvd.2024.10.324","DOIUrl":"10.1016/j.acvd.2024.10.324","url":null,"abstract":"<p><strong>Background: </strong>Demographic changes and improvements in the diagnosis and treatment of valvular heart diseases (VHDs) have led to changes in its epidemiological profile.</p><p><strong>Aims: </strong>To describe the epidemiology of VHD in France in 2022.</p><p><strong>Methods: </strong>Adults hospitalized due to VHD in 2022 were identified from the French National Health Data System and categorized by type of VHD on the basis of hospital diagnoses and interventions. Incidence and prevalence rates were calculated using national French demographic data.</p><p><strong>Results: </strong>In 2022, 51,894 adults (60.1% men) were hospitalized for VHD (97.0/100,000 inhabitants). The most frequently observed hospitalized VHDs were AS (61.6%) and MR (23.2%). The mean age at hospitalization was 74.0years, and this was higher for AS than MR (77.3 vs 71.2years). Infectious endocarditis was managed during the index hospitalization in 13.3% of patients. During the index hospitalization and the following 6months, 75.0% of patients underwent valve repair or replacement. Among hospitalized patients with AS, 56.9% had transcatheter aortic valve implantation and 24.9% had surgical aortic valve replacement. Among patients hospitalized for MR, 27.1% underwent surgical mitral valve repair, 12.7% transcatheter mitral valve repair and 19.1% mitral valve replacement. The all-cause death rate 1year after hospitalization for VHD was 13.7%. Overall, in France, on 1 January 2023, 1.90% of the adult population had VHD (2.08% of men and 1.72% of women). Overall, 363,574 had aortic stenosis (AS) and 409,570 had mitral regurgitation (MR).</p><p><strong>Conclusion: </strong>VHDs are a major burden in France, particularly degenerative valve diseases of the left heart in older adults.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"669-681"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estimation of the proportion of cardiovascular disease cases in France attributable to high concentrations of low-density lipoprotein cholesterol.","authors":"Amélie Gabet, Clémence Grave, Christophe Bonaldi, Jacques Blacher, Valérie Olié","doi":"10.1016/j.acvd.2024.11.001","DOIUrl":"10.1016/j.acvd.2024.11.001","url":null,"abstract":"<p><strong>Background: </strong>Elevated concentrations of low-density lipoprotein cholesterol (LDL-C) are highly prevalent and are associated with the development of cardiovascular diseases.</p><p><strong>Aim: </strong>To estimate the proportion of cardiovascular disease cases attributable to high concentrations of LDL-C (population attributable fraction [PAF]) in France in 2017, based on the most recent individual data on LDL-C, and the attributable burden on hospitalizations and death.</p><p><strong>Methods: </strong>We estimated the PAF of high LDL-C concentrations for ischaemic heart disease (IHD), ischaemic stroke and aortic valve stenosis (AVS). Distributions of LDL-C concentrations were obtained from the most recent French health examination representative survey (ESTEBAN). The relative risks of each disease per 1-mmol/L increase in blood LDL-C were obtained either from the most appropriate meta-analyses or from Mendelian randomization.</p><p><strong>Results: </strong>The PAF of high LDL-C concentrations varied between 44.2% (95% CI 24.6%-60.5%) for IHD-related death and 49.4% (95% CI 35.6-60.8%) for IHD-related years-of-life lost (YLL), 22.5% (95% CI 0.0-43.3%) and 25.5% (95% CI 11.6-36.8%) for ischaemic stroke indicators, and 29.0% (95% CI 8.6-45.4%) and 29.3% (95% CI 8.4-45.6%) for AVS indicators. Overall, 230,000 hospitalizations, 1,303,000 prevalent cases and 23,000 deaths were estimated to be attributable to high LDL-C concentrations, with most cases related to IHD. PAFs were similar across sex and cardiovascular diseases, whereas PAF strongly varied with age for IHD and ischaemic stroke, with PAF reaching 80.6% (95% CI 55.3-92.7%) and 60.9% (95% CI 33.8-80.8%), respectively, in the group aged 35-44 years.</p><p><strong>Conclusion: </strong>The high estimated PAF of elevated LDL-C concentrations for IHD, ischaemic stroke and AVS support the urgent need to reduce the prevalence of hypercholesterolaemia in this French population.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"660-668"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of cardiovascular risk factors: Non-behavioural risk factors.","authors":"Valérie Olié, Amélie Gabet, Clémence Grave, Gérard Helft, Sandrine Fosse-Edorh, Clara Piffaretti, Grégory Lailler, Charlotte Verdot, Valérie Deschamps, Juliette Vay-Demouy, Emmanuelle Vidal-Petiot, Beatrice Duly-Bouhanick, Philippe Tuppin, Jean Ferrières, Jean-Michel Halimi, Jacques Blacher","doi":"10.1016/j.acvd.2024.08.005","DOIUrl":"10.1016/j.acvd.2024.08.005","url":null,"abstract":"<p><p>Cardiovascular disease is the leading cause of death worldwide, and the second leading cause in France. Among the modifiable cardiovascular risk factors, metabolic diseases (hypertension, low-density lipoprotein hypercholesterolaemia, diabetes and obesity) play a major role, contributing to the development and progression of atherosclerosis. This review summarizes the latest epidemiological data available at a national level. In 2015, the prevalence among adults aged 18-74years was 17.2% for obesity, 7.4% for diabetes, 30.6% for hypertension, 23.3% for low-density lipoprotein hypercholesterolaemia and 1.5% for stage 3-5 chronic kidney disease. Awareness of these diseases among affected individuals was very poor, ranging from 23% for diabetes to 45% for hypertension. While the prevalence of obesity and hypertension remained stable between 2006 and 2015, the prevalence of diabetes increased significantly. Prevention of these risk factors, particularly through nutrition, as well as awareness and management of them, must be intensified to reduce the burden of cardiovascular diseases in France. Whereas the prevalence of metabolic factors remains higher in men, particular attention should also be paid to risk factors specific to women, such as gynaecological diseases (endometriosis, polycystic ovary syndrome) and pregnancy disorders (hypertensive disorders in pregnancy, gestational diabetes), which contribute significantly to cardiovascular risk.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"761-769"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of cardiovascular risk factors: Behavioural risk factors.","authors":"Valérie Olié, Clémence Grave, Gérard Helft, Viet Nguyen-Thanh, Raphaël Andler, Guillemette Quatremere, Anne Pasquereau, Emmanuel Lahaie, Grégory Lailler, Charlotte Verdot, Valérie Deschamps, Juliette Vay-Demouy, Daniel Thomas, François Paillard, Philippe Tuppin, Marie-Christine Iliou, Jacques Blacher, Amélie Gabet","doi":"10.1016/j.acvd.2024.10.328","DOIUrl":"10.1016/j.acvd.2024.10.328","url":null,"abstract":"<p><p>Cardiovascular diseases (CVDs) have a multifactorial origin. Among the risk factors, so-called behavioural risk factors play a major role in the onset of these diseases: smoking, unhealthy diet, lack of physical activity and sedentary lifestyle, alcohol, sleep disorders, depression and illicit drug use are among the main behavioural risk factors for CVD and are considered to be modifiable and accessible to prevention. The prevalence of these cardiovascular risk factors remains high among the French population. Nearly one in three adults are smokers, 71.7% do not meet the recommendation to eat five fruits and vegetables per day, and 4 out of 5 adults consume more than 6g of salt per day. Further, 38.7% of adults do not meet the recommendations for physical activity, 40.8% have a high level of sedentary, 49.4% report sleep problems in the last 8 days, and 12.5% have had a major depressive episode in the last 12 months. Despite some positive trends, such as an increase in the level of physical activity among men and the decline in smoking prevalence, the epidemiological situation regarding these risk factors remains a cause for concern in France. While the gap between risk factors in men and women is narrowing, this is often due to a worsening of the situation among women, who are increasingly adopting unfavourable behaviours and tending to reach the higher levels of risk factors traditionally observed among men. The epidemiological situation demonstrates the urgent need to strengthen policies to prevent these risk factors.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"770-784"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of stroke in France.","authors":"Amélie Gabet, Yannick Béjot, Emmanuel Touzé, France Woimant, Laurent Suissa, Clémence Grave, Grégory Lailler, Philippe Tuppin, Valérie Olié","doi":"10.1016/j.acvd.2024.10.327","DOIUrl":"10.1016/j.acvd.2024.10.327","url":null,"abstract":"<p><strong>Background: </strong>It has been nearly 10years since the first national stroke plan in France.</p><p><strong>Aims: </strong>To examine the epidemiology of strokes, how they are managed and patient outcomes.</p><p><strong>Methods: </strong>Adults hospitalized for stroke in 2022 were identified in the national database. Stroke prevalence at 1 January 2023 was defined as the number of people alive at that date with a history of hospitalization for stroke or a chronic long-term disease status due to stroke (2012-2022). Patients were monitored up for up to 1year after hospitalization for a stroke.</p><p><strong>Results: </strong>In 2022, 122,422 adults were hospitalized due to stroke, and there were an estimated 1,086,795 cases. Important geographical and socioeconomic disparities were observed. Admission to a stroke intensive care unit was found in 46.8% of patients, with significant variations by department of residence, age and gender. Only 7.2% of ischaemic strokes resulted in mechanical thrombectomy. Among survivors at 6months, admission to a rehabilitation unit was found for 34.3% for patients with ischaemic strokes and 41.7% of those with haemorrhagic strokes, while 28.8% and 18.8%, respectively, had a consultation with a neurologist, and 19.5% and 10.9% were seen by a cardiologist within 6months. Mortality rates after 1year were 20.8% and 37.9% among patients hospitalized due to ischaemic and haemorrhagic strokes, respectively.</p><p><strong>Conclusion: </strong>The considerable numbers and rates of stroke - and disparities by age, sex and area - highlight the need for more effective stroke prevention, regular information campaigns on the symptoms of stroke and improved availability and accessibility of stroke units.</p>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":" ","pages":"682-692"},"PeriodicalIF":2.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142795671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}